Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · MA · Oct 29, 2009 → May 2, 2024
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
John Ripple is listed as an executive officer and director on 10 SEC Form D filings by 4 issuers between Oct 2009 and May 2024: Virdante Pharmaceuticals, Inc. (Cambridge, MA — pharmaceuticals — 2009–2011; $30.1M reported sold to 10 investors), Exonics Therapeutics, Inc. (Watertown, MA — biotechnology — 2017–2018; $22M reported sold to 2 investors), Lucy Therapeutics, Inc. (Waltham, MA — pharmaceuticals — 2020–2024; $15M reported sold to 6 investors) and Praesidia Biotherapeutics, Inc. (Arlington, MA — biotechnology — 2022; $7.42M reported sold to 55 investors).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 15 years. Across those companies the filings report $74.6M sold in total.
Listed alongside Amy Ripka (4 shared filings), Anders Hove (3 shared filings), Eric Aguiar (3 shared filings), Gail Wasserman (3 shared filings), L. Patrick Gage (3 shared filings) and 14 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 28 court cases matching the name, 2 SEC releases, 13 bankruptcy cases matching the name listed in Key records below.
What this means 43 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 10 public filings for John Ripple and found 8 differences, 2 worth asking the sponsor about: Regulator action: Ripple Labs, Inc., Bradley Garlinghouse, and Christian A. Larsen (Aug 7, 2025); Regulator action: Ripple Labs, Inc., Bradley Garlinghouse, and Christian Larsen (May 8, 2025); and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for John Ripple has not run yet — it is joining a line of 46,944 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.
Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.
Five things investors ask first. Items still in human review are counted, not shown.
28 cases: 2 open, 16 closed (disposition not in docket feed), 9 dismissed, 1 judgment
690 Forfeit/Penalty: Other· Cause:
18:981 Civil Forfeiture
Contract: Other· Cause:
28:1330 Breach of Contract
370 Other Fraud· Cause:
28:1332 Diversity-Fraud
370 Other Fraud· Cause:
28:1332 Diversity-Fraud
850 Securities/Commodities· Cause:
15:77 Securities Fraud
850 Securities/Commodities· Cause:
28:1331 Fed. Question: Securities Violation
850 Securities/Commodities· Cause:
15:78m(a) Securities Exchange Act
850 Securities/Commodities· Cause:
28:1331sv Fed. Question: Securities Violation
190 Other contract actions
190 Other contract actions
Securities/Commodities· Cause:
28:1332 Diversity-Petition for Removal
160 Stockholders Suits· Cause:
28:1332 Diversity-Petition for Removal
850 Securities/Commodities· Cause:
15:77 Securities Fraud
190 Contract: Other· Cause:
28:1332 Diversity-Other Contract
890 Other Statutory Actions· Cause:
47:227(b)(3) Telephone Consumer Protection Act of 1991
890 Other Statutory Actions· Cause:
28:1332 Diversity-Interpleader Action
367 Health care / pharm
290 Real Property: Other· Cause:
Diversity
480 Consumer Credit· Cause:
15:1681 Fair Credit Reporting Act
890 Other Statutory Actions· Cause:
Civil Miscellaneous Case
Agriculture Acts· Cause:
07:499 Agricultural Commodities Act
Agriculture Acts· Cause:
07:499 Agricultural Commodities Act
Contract: Other· Cause:
28:1332 Diversity-Breach of Contract
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
2 SEC releases
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched John Ripple..
State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).
13 cases: 13 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
8 differences found between the filings for John Ripple — 2 worth asking about (compared 10 filings on Oct 24, 2026)
An SEC litigation release dated Aug 7, 2025 names John Ripple. Our match estimate: 40%. The release is the source; we do not summarize its outcome here.
What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.
An SEC litigation release dated May 8, 2025 names John Ripple. Our match estimate: 40%. The release is the source; we do not summarize its outcome here.
What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.
Praesidia Biotherapeutics, Inc. (last filing Jul 17, 2024; $7,420,000 sold of $15,000,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
No amendment in the last 12 months on an offering that may still be open — Praesidia Biotherapeutics, Inc. (latest filing Aug 23, 2022) · No amendment in the last 12 months on an offering that may still be open — Lucy Therapeutics, Inc. (latest filing Jan 6, 2022) · No amendment in the last 12 months on an offering that may still be open — Lucy Therapeutics, Inc. (latest filing Jul 22, 2020) · No amendment in the last 12 months on an offering that may still be open — Exonics Therapeutics, Inc. (latest filing Nov 20, 2018) · No amendment in the last 12 months on an offering that may still be open — Virdante Pharmaceuticals, Inc. (latest filing Oct 14, 2011)
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
The Dec 26, 2023 filing says $9,000,000 offered; the May 2, 2024 Form D/A says $10,552,797.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The Jul 15, 2019 filing says $3,500,000 offered; the Jul 22, 2020 Form D/A says $4,509,472.
What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.
The people listed on the Jan 6, 2022 filing give Cambridge, MA; on the Dec 26, 2023 filing they give Waltham, MA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
The people listed on the Nov 20, 2017 filing give Cambridge, MA; on the Nov 20, 2018 filing they give Watertown, MA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
1 of 6 offerings reports sales commissions totalling $700,000; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| May 2, 2024 D/A Lucy Therapeutics, Inc. File 021-500678 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 23, 2022 D/A Praesidia Biotherapeutics, Inc. File 021-409716 | $700,000 (est.) | $0 | $0 (est.) Proceeds of the offering will be used for general working capital of the issuer, including payment of salaries to officers. | Wilmington Capital Securities, LLC BrokerCheck CRD 133839 ↗ | EDGAR ↗ |
| Jan 6, 2022 D Lucy Therapeutics, Inc. File 021-428117 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 22, 2020 D/A Lucy Therapeutics, Inc. File 021-344266 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 20, 2018 D/A Exonics Therapeutics, Inc. File 021-299113 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Oct 14, 2011 D/A Virdante Pharmaceuticals, Inc. File 021-114968 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named John Ripple on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $15M from 6 investors (100% of the $10.6M target) as of the latest filing. John is listed as director on 4 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $7.42M from 55 investors (74% of the $10M target) as of the latest filing. John is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $22M from 2 investors (52% of the $42M target) as of the latest filing. John is listed as executive officer, director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $30.1M from 10 investors (63% of the $47.8M target) as of the latest filing. John is listed as executive officer, director on 3 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.
Michael Steinmetz is on 7 issuers in total — a repeat sponsor. Their page lists every one.
David Goeddel is on 20 issuers in total — a repeat sponsor. Their page lists every one.
Ann DeWitt is on 10 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as John Ripple. Their page shows their other deals.
Listed on the same filings as John Ripple. Their page shows their other deals.
Listed on the same filings as John Ripple. Their page shows their other deals.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).
None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to John Ripple by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.
Websites and social links of the issuers John Ripple is listed on: none on file. No website or social profile named in Virdante Pharmaceuticals, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #347,454 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when John Ripple appears on a new Form D, or when a court case or SEC action is matched to them. See plans →